- Home
- / OptimizeRx
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Financial statements
| USD | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 24.6M | 43.3M | 61.3M |
| Revenue growth, % | 41.5% | ||
| Cost of goods sold | 9.2M | 19.2M | 25.7M |
| Gross profit | 15.4M | 24.1M | 35.6M |
| Gross profit margin, % | 62.8% | 55.7% | 58.1% |
| General and administrative expense | 15.6M | 21.0M | 27.7M |
| Operating expense total | 19.1M | 26.2M | 35.3M |
| Depreciation and amortization | 1.3M | 2.1M | 2.1M |
| EBIT | (3.7M) | (2.1M) | 361.1K |
| EBIT margin, % | -15.0% | -4.9% | 0.6% |
| Interest income | 288.0K | 68.6K | 17.0K |
| Pre tax profit | (4.0M) | (2.2M) | 378.1K |
| Income tax expense | (898.0K) | ||
| Net Income | (3.1M) | (2.2M) | 378.1K |
| EPS | (0.2) | (0.1) | 0.0 |